toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Record Links
Author (up) Liu, J.Z.; Hov, J.R.; Folseraas, T.; Ellinghaus, E.; Rushbrook, S.M.; Doncheva, N.T.; Andreassen, O.A.; Weersma, R.K.; Weismuller, T.J.; Eksteen, B.; Invernizzi, P.; Hirschfield, G.M.; Gotthardt, D.N.; Pares, A.; Ellinghaus, D.; Shah, T.; Juran, B.D.; Milkiewicz, P.; Rust, C.; Schramm, C.; Muller, T.; Srivastava, B.; Dalekos, G.; Nothen, M.M.; Herms, S.; Winkelmann, J.; Mitrovic, M.; Braun, F.; Ponsioen, C.Y.; Croucher, P.J.P.; Sterneck, M.; Teufel, A.; Mason, A.L.; Saarela, J.; Leppa, V.; Dorfman, R.; Alvaro, D.; Floreani, A.; Onengut-Gumuscu, S.; Rich, S.S.; Thompson, W.K.; Schork, A.J.; Naess, S.; Thomsen, I.; Mayr, G.; Konig, I.R.; Hveem, K.; Cleynen, I.; Gutierrez-Achury, J.; Ricano-Ponce, I.; van Heel, D.; Bjornsson, E.; Sandford, R.N.; Durie, P.R.; Melum, E.; Vatn, M.H.; Silverberg, M.S.; Duerr, R.H.; Padyukov, L.; Brand, S.; Sans, M.; Annese, V.; Achkar, J.-P.; Boberg, K.M.; Marschall, H.-U.; Chazouilleres, O.; Bowlus, C.L.; Wijmenga, C.; Schrumpf, E.; Vermeire, S.; Albrecht, M.; Rioux, J.D.; Alexander, G.; Bergquist, A.; Cho, J.; Schreiber, S.; Manns, M.P.; Farkkila, M.; Dale, A.M.; Chapman, R.W.; Lazaridis, K.N.; Franke, A.; Anderson, C.A.; Karlsen, T.H. url  doi
  Title Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis Type Journal Article
  Year 2013 Publication Nature Genetics Abbreviated Journal Nat Genet  
  Volume 45 Issue 6 Pages 670-675  
  Keywords Case-Control Studies; Cholangitis, Sclerosing/*genetics/immunology; Gene Frequency; Genetic Loci/immunology; Genetic Pleiotropy; Genome-Wide Association Study; Genotyping Techniques; Humans; Linkage Disequilibrium; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Risk Factors  
  Abstract Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation. We compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip. We identified 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly stronger association with PSC than with IBD, suggesting overlapping yet distinct genetic architectures for these two diseases. We incorporated association statistics from 7 diseases clinically occurring with PSC in the analysis and found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together with network analyses, these findings add to the genetic risk map of PSC and expand on the relationship between PSC and other immune-mediated diseases.  
  Address Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK  
  Corporate Author International PSC Study Group Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1061-4036 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:23603763; PMC3667736 Approved no  
  Call Number HUNT @ maria.stuifbergen @ Serial 1427  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: